相关实验视频

Updated: Jan 7, 2026

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

利用多价值和FcγRIIB参与来增强抗CD27免疫疗法

Marcus A Widdess¹, Anastasia Pakidi¹, Hannah J Metcalfe¹

¹Antibody and Vaccine Group, Centre for Cancer Immunology, School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Nature communications

|December 20, 2025

概括

工程化四价抗CD27抗体通过增加抗体价值和Fc受体参与来增强T细胞激活和抗瘤免疫力. 这一策略改善了对抗癌症的T细胞刺激疗法.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

检查点封锁免疫疗法显示出希望,但面临的局限性,如耐药性和毒性.
激活共刺激受体是促进抗瘤免疫力的潜在策略.
模仿生理膜固的共刺激联体需要进一步的研究.

研究的目的:

开发用于共刺激受体CD27.7的有效激动剂.
通过改造抗体特性来增强抗瘤免疫力.
了解提高激动剂疗效背后的机制.

主要方法:

设计具有增强FcγRIIB参与度的四价抗CD27抗体.
在临床前模型中评估T细胞刺激活性和抗瘤疗效.
研究抗体价值和FcγRIIB相互作用对受体聚类和内部化的机制影响.

主要成果:

与双价抗体相比,四价抗体抗CD27抗体显示出强大的T细胞刺激和抗瘤疗效.
抗瘤效应是由CD8+ T细胞激活的介导而不会耗尽调节性T细胞.
增加的贪增强了CD27的聚类,而FcγRIIB的参与促进了群集的两极分化和减少了内部化.

结论:

针对CD27的工程四价抗体为增强T细胞介导的抗瘤免疫提供了一个有希望的方法.
增加抗体价值和FcγRIIB参与的组合代表了开发新型免疫疗法的可行策略.
这项工作为设计下一代基于激素的T细胞刺激疗法提供了框架.

更多相关视频

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...